You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤雙鶴(600062.SH)衝高回落 近1個月已累漲超80%
格隆匯 04-14 12:01
格隆匯4月14日丨近期走勢強勁的華潤雙鶴(600062.SH)盤中一度再漲停,隨後衝高回落,截至半日收盤漲1.78%報19.45元,市值203億元。華潤雙鶴近期備受市場關注,3月17日至今的大約1個月內一度累漲超80%。主因該公司此前曾被傳將在3月底和真實生物簽訂代理生產、銷售抗病毒藥物阿茲夫定的協議。昨日又有市場傳聞稱,真實生物的阿茲夫定揭盲數據將公佈,且傳華潤雙鶴拿到訂單。不過值得注意的是,截至當前,華潤雙鶴並沒有正式發佈和真實生物相關的合作公吿。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account